{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:51Z","timestamp":1790716611392,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.maturitas.2003.11.009","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T06:29:34Z","timestamp":1079504974000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Are all estrogens the same?"],"prefix":"10.1016","volume":"47","author":[{"given":"Herjan J.T.","family":"Coelingh Bennink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.maturitas.2003.11.009_BIB1","first-page":"S1","article-title":"Chemistry, physiology, and pharmacology of sex steroids","volume":"28","author":"Birkhauser","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB2","unstructured":"Williams CL, Stancel GM. Estrogens and progestins. In: Hardman JG, Gilman AG, Limbird LE (Eds.), Goodman and Gilman\u2019s\u2014the pharmacological basis of therapeutics. New York: McGraw-Hill; 1995. p. 1411\u201340."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/jcem-40-3-518","article-title":"Circulating estradiol, estrone, and gonadotropin levels following the administration of orally active 17\u03b2-estradiol in postmenopausal women","volume":"40","author":"Yen","year":"1975","journal-title":"J. Clin. Endocrinol Metab."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0889-8545(21)00577-5","article-title":"Absorption and metabolic effects of different types of estrogens and progestogens","volume":"14","author":"Lobo","year":"1987","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB5","first-page":"771","article-title":"Oral menopausal therapy using 17\u03b2-micronized estradiol","volume":"39","author":"Martin","year":"1971","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/03009738109179241","article-title":"Oral versus vaginal absorption of oestradiol in postmenopausal women. Effects of different particle sizes","volume":"86","author":"Englund","year":"1981","journal-title":"Upsala J. Med. Sci."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0378-5122(81)90036-0","article-title":"Bioavailability of oestradiol and oestriol administered orally to oophorectomised women","volume":"3","author":"Fink","year":"1981","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0002-9378(85)90569-1","article-title":"Pharmacokinetics and pharmacodynamics of transdermal dosage forms of estradiol: comparison with conventional oral estrogens used for hormone replacement","volume":"152","author":"Powers","year":"1985","journal-title":"Am. J. Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1989.tb02232.x","article-title":"Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotropin release, bone turnover and climacteric symptoms in postmenopausal women","volume":"30","author":"Selby","year":"1989","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.maturitas.2003.11.009_BIB10","first-page":"758","article-title":"Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol","volume":"77","author":"Scott","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(79)90018-4","article-title":"Metabolism of estrogens\u2014natural and synthetic","volume":"4","author":"Bolt","year":"1979","journal-title":"Pharmac Ther"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-5122(90)90003-O","article-title":"Pharmacokinetics of oestrogens and progestogens","volume":"12","author":"Kuhl","year":"1990","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB13","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1097\/00006250-199004001-00003","article-title":"Pharmacokinetics of estrogen","volume":"75","author":"Stumpf","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB14","unstructured":"Von Schoultz B. Potency of different oestrogen preparations. In: Studd JWW, Whitehead MI (Eds.), The menopause. Oxford: Blackwell Scientific Publications; 1988. p. 130\u20137."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB15","unstructured":"Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. Baltimore: Lippincott Williams and Wilkins; 1999."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(99)00021-3","article-title":"Absorption and bioavailability of oestradiol from a gel, a patch and a tablet","volume":"32","author":"J\u00e4rvinen","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB17","doi-asserted-by":"crossref","unstructured":"The Writing Group for the PEPI Trial. Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. JAMA 1995; 273(3):199\u2013208.","DOI":"10.1001\/jama.1995.03520270033028"},{"issue":"7","key":"10.1016\/j.maturitas.2003.11.009_BIB18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"Suppl. 16","key":"10.1016\/j.maturitas.2003.11.009_BIB19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1471-0528.1997.tb11561.x","article-title":"The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy","volume":"104","author":"Crook","year":"1997","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB20","first-page":"61","article-title":"Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations","volume":"94","author":"Mattsson","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.maturitas.2003.11.009_BIB21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0002-9378(95)90249-X","article-title":"Emerging delivery systems for estrogen replacement: aspects of transdermal and oral delivery","volume":"173","author":"Nachtigall","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1742-1241.1999.tb11775.x","article-title":"Current hormone replacement therapy: what are the shortcomings? Advances in delivery","volume":"53","author":"Sturdee","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","article-title":"Increased risk of endometrial cancer among users of conjugated estrogens","volume":"293","author":"Ziel","year":"1975","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB24","first-page":"265","article-title":"Estrogen replacement therapy and endometrial cancer risk: unresolved issues","volume":"81","author":"Brinton","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM198510173131601","article-title":"Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens","volume":"313","author":"Shapiro","year":"1985","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose","year":"1996","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB27","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/00006250-199004001-00013","article-title":"The role and use of progestogens","volume":"75","author":"Whitehead","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00016348509154686","article-title":"Effect of long-term therapy with estrogen and progesterone on the endometrium of postmenopausal women","volume":"64","author":"Varma","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(88)90824-0","article-title":"Consensus conference: progestagen use in postmenopausal women","volume":"2","author":"Whitehead","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB30","first-page":"726","article-title":"Initial 17\u03b2-estradiol dose for treating vasomotor symptoms","volume":"95","author":"Notelovitz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB31","first-page":"722","article-title":"Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women. Second report of the Hormones and Urogenital Therapy Committee","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB32","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1097\/00006250-199004001-00008","article-title":"Pathogenesis, prevention and treatment of osteoporosis","volume":"75","author":"Stevenson","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB33","first-page":"329","article-title":"Progestins and their application in the menopause. What have we learned","volume":"10","author":"Liu","year":"1999","journal-title":"Infert Reprod Med Clinical N Am"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB34","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/0002-9378(87)90025-1","article-title":"Estrogen therapy arrests bone loss in elderly women","volume":"156","author":"Quigley","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9378(92)91653-R","article-title":"Low-dosage micronized 17\u03b2-estradiol prevents bone loss in postmenopausal women","volume":"166","author":"Ettinger","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9378(92)91653-R","article-title":"Low dosage micronized 17\u03b2-estradiol prevents bone loss in postmenopausal women","volume":"166","author":"Ettinger","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB37","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium and lipid levels","volume":"157","author":"Genant","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9378(97)70448-4","article-title":"Bone loss in elderly women prevented by ultralow doses of parenteral 17\u03b2-estradiol","volume":"177","author":"Naessen","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jcem-55-6-1124","article-title":"Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose\u2212response relationships in early postmenopausal women","volume":"55","author":"Christiansen","year":"1982","journal-title":"J. Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.maturitas.2003.11.009_BIB40","first-page":"950","article-title":"Use of low dosage 17\u03b2\u2212estradiol for the prevention of osteoporosis","volume":"15","author":"Ettinger","year":"1993","journal-title":"Clin Ther"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB41","doi-asserted-by":"crossref","unstructured":"Consensus Development Conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94(6):646\u201350.","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB42","doi-asserted-by":"crossref","unstructured":"Consensus Development Conference: prophylaxis and treatment of osteoporosis. Osteoporosis Int 1991;1:114\u20137.","DOI":"10.1007\/BF01880454"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB43","unstructured":"Riis BJ. How should HRT be used in the prevention and treatment of osteoporosis? In: Birkh\u00e4user MH, Rozenbaum H (Eds.), Menopause. European Consensus Development Conference. Montreux. Switzerland, 8\u201310 September 1995. Paris: Editions Eska; 1996. p.111\u20136."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB44","unstructured":"World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843, 1994."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB45","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women\u2019s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 2002;288:321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB46","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.88.5.2163","article-title":"Associations of postmenopausal oestrogen use with cardiovascular disease and its risk factors in older women","volume":"88","author":"Manolio","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB47","doi-asserted-by":"crossref","unstructured":"U.S. Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med 2002;137:834\u20139.","DOI":"10.7326\/0003-4819-137-10-200211190-00013"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen\/progestin replacement study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0002-9343(99)00063-7","article-title":"Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis","volume":"106","author":"Grodstein","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB50","first-page":"880","article-title":"Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis","volume":"93","author":"Nanda","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.maturitas.2003.11.009_BIB51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/87.14.1067","article-title":"Postmenopausal hormone use and risk of large-bowel cancer","volume":"87","author":"Newcomb","year":"1995","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular outcomes during 6.8 years of hormone therapy. Heart and Estrogen\/Progestin Replacement Study Follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB53","unstructured":"Premarin patient information. Updated 23 January 2003. Available at http:\/\/www.premarin.com (addressed 10 March 2003)."},{"key":"10.1016\/j.maturitas.2003.11.009_BIB54","first-page":"1047","article-title":"For the Collaborate Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy","volume":"350","author":"Beral","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB55","first-page":"449","article-title":"Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States","volume":"7","author":"Willis","year":"1996","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB58","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2003.11.009_BIB59","first-page":"5","article-title":"Postmenopausal hormone use and cholecystectomy in a large prospective study","volume":"83","author":"Grodstein","year":"1994","journal-title":"Obstet Gynecol"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512204000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512204000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:38:27Z","timestamp":1759912707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512204000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0378512204000143"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2003.11.009","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are all estrogens the same?","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2003.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}